NuCana (NCNA) vs Propanc Biopharma (PPCB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Propanc Biopharma is the larger company by market cap ($4.9 million vs $4.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | NCNA | PPCB |
|---|---|---|
| Share price | $1.14 | $0.4987 |
| Market cap | $4.74M | $4.90M |
| 1-day change | +4.59% | +1.51% |
| EPS (TTM) | $0.00 | $-17.62 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.65 | $49.25 |
| 52-week low | $0.948 | $0.46 |
| Distance from 52-week high | -82.86% | -98.99% |
| Average volume | 124.81K | 1.78M |
| Shares outstanding | 4.16M | 9.83M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
NCNA vs PPCB FAQ
Which is bigger, NuCana or Propanc Biopharma?
Propanc Biopharma (PPCB) is larger, with a market capitalization of $4.90M compared with $4.74M for NuCana (NCNA).
Are NuCana and Propanc Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.